Netherlands startup funding in Q1 2022
European tech funding raised by Netherlands startups during Q1 2022.
In Q1 2022, 69 startups in the Netherlands closed 69 funding rounds and raised €1.3B in equity funding (excluding debt and grants), up 139.2% versus Q1 2021. Healthtech was the most active sector, and INKEF Capital was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.3B
+139.2% vs Q1 2021 · excl. debt & grants
Funding rounds
69
+130.0% vs Q1 2021
Companies
69
Top sector
Healthtech
Rank in Europe
#5
3.9% of European funding
Top-10 round share
73.1%
of disclosed capital
Rounds ≥ €100M
2
Funding by month
€ raised vs rounds, by monthNetherlands — funding by month, Q1 2022 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €625M | 26 |
| Feb | €418M | 22 |
| Mar | €267M | 21 |
Top sectors
by € raisedNetherlands — top sectors by capital, Q1 2022 — interactive chart.
Data table
| Netherlands — top sectors by capital, Q1 2022 | |
|---|---|
| Software | €383M |
| Healthtech | €362M |
| Fintech | €156M |
| Agritech | €143M |
| Transportation | €117M |
| Marketing | €55M |
| E-commerce | €48M |
| Edtech | €29M |
Stage mix
by € raisedNetherlands — stage mix, Q1 2022 — interactive chart.
Data table
| Netherlands — stage mix, Q1 2022 | |
|---|---|
| Series B | €365M |
| Series C | €353M |
| Series A | €315M |
| Other | €244M |
| Seed | €31M |
| Pre-Seed | €1.1M |
Exits & M&A
32 Acquisition · 1 IPO · 1 Merger34 exits · €1.7B disclosed.
| Accell Group | Acquisition | Jan 2022 | €1.6B |
| Azerion | IPO | Feb 2022 | €93M |
| Cybersprint | Acquisition | Feb 2022 | €48M |
| Liones Holding | Acquisition | Mar 2022 | €18M |
Top deals
largest disclosed rounds in Q1 2022| Company | Stage | Date | Amount |
|---|---|---|---|
| Miro | Series C | Jan 2022 | €353M |
| Leyden Labs | Series B | Jan 2022 | €124M |
| Moove Africa | Series A | Mar 2022 | €96M |
| Ambagon Therapeutics | Series A | Jan 2022 | €75M |
| Dott | Series B | Feb 2022 | €70M |
| Channable | Series B | Feb 2022 | €55M |
| Protix | Other | Feb 2022 | €50M |
| PlantLab | Other | Feb 2022 | €50M |
| ChannelEngine | Series B | Mar 2022 | €45M |
| TargED Biopharmaceutical | Series A | Feb 2022 | €39M |
| TargED Biopharmaceuticals | Series A | Feb 2022 | €39M |
| In Ovo | Series B | Mar 2022 | €34M |
| ParkBee | Other | Mar 2022 | €30M |
| Scenic Biotech | Series A | Mar 2022 | €28M |
| StudyTube | Series B | Feb 2022 | €27M |
Top investors
most active in Q1 2022, by deal count- INKEF Capital5 deals
- Rabobank4 deals
- 4impact capital3 deals
- ASIF Ventures3 deals
- BNP Paribas2 deals
- ABN AMRO2 deals
- Utrecht Health Seed Fund2 deals
- InnovationQuarter2 deals
- Newion2 deals
- Peak Capital2 deals